Filter programs:

53 Programs

  • Oncology Today with Dr Neil Love

    The Role of Oral Selective Estrogen Receptor Degraders in the Management of ER-Positive Metastatic Breast Cancer

    Explore program
  • 5-Minute Journal Club

    Defining the Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer — Issue 4

    Explore program
  • Webinar Proceedings

    Current and Future Integration of Antibody-Drug Conjugates into the Management of Metastatic Breast Cancer

    Explore program
  • Webinar Proceedings

    The Implications of Recent Datasets for the Current and Future Management of Breast Cancer — An ASCO 2025 Review

    Explore program